Written by Klara Rombauts, Arne Heyerick and the CAM-Cancer Consortium.
Updated March 30, 2011

Artemisia annua

What is it ?

Scientific name(s)/brand name(s)/common name(s)

Artemisia annua L., also known as sweet wormwood, sweet annie, sweet sagewort and annual wormwood (Chinese: qīnghāo), is a common type of wormwood that is native to temperate Asia, but naturalized throughout the world, and that belongs to the family of Asteraceae. It has fern-like leaves, bright yellow flowers, and a camphor-like scent. Glandular structures (trichomes) producing a wide range of bioactive compounds (mostly terpenoids) can be found on the surface of leaves, stems and flowers.

Ingredient(s)

The phytochemical composition of Artemisia annua has been reviewed in great detail by Bhakuni et al. 2. The most relevant compounds are sesquiterpenoids (ex. artemisinin), triterpenoids, flavonoids (polymethoxylated flavonoids), chromenes 2 and essential oil components.

Besides Artemisia annua itself, this summary also reviews current literature on artesunate, dihydroartemisinin and artemether. Artesunate, dihydroartemisinin and artemether are semi-synthetic derivatives of artemisinin. Much more research has been published on the effect of these compounds than on artemisinin itself. Arteether, another semisynthetic derivative that has been used in antimalarial treatment has not been the focus of anticancer research to date.

Application and dosage

There is no documented safe or effective dose for the possible use of Artemisia annua derived products for the treatment of cancer in adults or children. However, information on dosage from traditional use of herbal preparations for other indications is available 3. In addition, artemisinin and its semisynthetic derivatives are used in antimalarial treatment in artemisinin-based combination therapies 4.

History

Sweet wormwood was used by Chinese herbalists in ancient times to treat specific fevers, but had fallen out of common use, until it was rediscovered in 1970 when the Chinese Handbook of Prescriptions for Emergency Treatments (340 AD) was recovered. This ancient pharmacopeia contained a recipe for a tea from the dried leaves of A. annua to be used in case of specific fevers. In 1971, scientists demonstrated that the plant extracts had antimalarial properties in primate models 5.

Mechanism of anti-cancer action

Artemisinin, the natural endoperoxide of Artemisia annua, and its semisynthetic derivates dihydroartemisinin, arthemether, artheether and artesunate are considered to be the primary active constituents for antimalarial and anti-cancer activity 6-7. Also the polymethoxyflavanoids are indicated as important compounds with potential anticancer activity. Cancer cell lines show a differential sensitivity as well as resistance to this group of compounds. Different genes which influence the sensitivity or the resistance to treatment have been identified. These genes could potentially function as markers indicating the expected efficacy of a clinical therapy 8-9. In contrast to popular belief that the cytotoxic activities would only be due to the non-specific generation of reactive oxygen species (ROS), it has become clear that artemisinin-related endoperoxides additionally have various specific molecular targets and can significantly influence the expression of key regulatory proteins of the cell cycle 6-7,9-10. Artemisinin-related endoperoxides were found to significantly inhibit angiogenesis and also to induce apoptosis 6,11. Iron plays a crucial role in the cytotoxic activities of artemisinin-related endoperoxides through the generation of both ROS and carbon-centered radicals. In general, the addition of iron has been shown to enhance both the cytotoxicity and selectivity of the treatment, but not in all cell lines 6-11.

Alleged indications

Apart from malaria, Artemisia annua is also used in cases of fever, headaches, infections and inflammations 12.

There is no data available on the prevalence of use of Artemisia annua in the treatment of cancer.

Legal issues

There are no Artemisia annua derived drugs that are approved for cancer treatment.

Cost(s) and expenditures

Prices available on the internet for artesunate range between $0.30 and $0.70 for a 100mg tablet or capsule.

Citation

Klara Rombauts, Arne Heyerick, CAM-Cancer Consortium. Artemisia annua [online document]. http://www.cam-cancer.org/CAM-Summaries/Herbal-products/Artemisia-annua. March 30, 2011.

Document history

Summary currently being updated.
Summary first published in March 2011, authored by Klara Rombauts and Arne Heyerick.

References

  1. Adisa R, Fakeye TO, Dike D. Evaluation of Adverse Drug Reactions to Artemisinin-based Combination Therapy in a Nigeria University community. Tropical Journal of Pharmaceutical Research 2008 Jun 20;7(2):937-44.
  2. Bhakuni RS, Jain D, Sharma RP, Kumar S. Secondary metabolites of Artemisia annua and thier biological activity. Current science 2001;80(1):35-48.
  3. Natural Standard. Monograph on Artemisia annua. Natural Standard 2010. Available from: URL: www.naturalstandard.com
  4. World Health Organization (WHO). WHO monograph on good agricultural and collection practices (GACP) for Artemisia annua L. 2006.
  5. van Agtmael MA, Eggelte TA, van Boxtel CJ. Artemisinin drugs in the treatment of malaria: from medicinal herb to registered medication. Trends Pharmacol Sci 1999 May;20(5):199-205.
  6. Firestone GL, Sundar SN. Anticancer activities of artemisinin and its bioactive derivatives. Expert Rev Mol Med 2009;11:e32.
  7. Efferth T. Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells. Curr Drug Targets 2006 Apr;7(4):407-21.
  8. Li LN, Zhang HD, Yuan SJ, Yang DX, Wang L, Sun ZX. Differential sensitivity of colorectal cancer cell lines to artesunate is associated with expression of beta-catenin and E-cadherin. Eur J Pharmacol 2008 Jun 24;588(1):1-8.
  9. Huang XJ, Ma ZQ, Zhang WP, Lu YB, Wei EQ. Dihydroartemisinin exerts cytotoxic effects and inhibits hypoxia inducible factor-1alpha activation in C6 glioma cells. J Pharm Pharmacol 2007 Jun;59(6):849-56.
  10. Li LN, Zhang HD, Yuan SJ, Tian ZY, Wang L, Sun ZX. Artesunate attenuates the growth of human colorectal carcinoma and inhibits hyperactive Wnt/beta-catenin pathway. Int J Cancer 2007 Sep 15;121(6):1360-5.
  11. Chen HH, Zhou HJ, Wu GD, Lou XE. Inhibitory effects of artesunate on angiogenesis and on expressions of vascular endothelial growth factor and VEGF receptor KDR/flk-1. Pharmacology 2004 May;71(1):1-9.
  12. MSKCC. MSKCC summary on Artemisia annua L. Memorial Sloan Kettering Cancer Center 2010. Available from: URL: http://www.mskcc.org/mskcc/html/69126.cfm
  13. Zhang ZY, Yu SQ, Miao LY, Huang XY, Zhang XP, Zhu YP, et al. [Artesunate combined with vinorelbine plus cisplatin in treatment of advanced non-small cell lung cancer: a randomized controlled trial]. Zhong Xi Yi Jie He Xue Bao 2008 Feb;6(2):134-8.
  14. Singh NP, Verma KB. Case report of a laryngeal squamous cell carcinoma treated with artesunate. Archive of Oncology 2002;10(4):279-80.
  15. Berger TG, Dieckmann D, Efferth T, Schultz ES, Funk JO, Baur A, et al. Artesunate in the treatment of metastatic uveal melanoma--first experiences. Oncol Rep 2005 Dec;14(6):1599-603.
  16. Singh NP, Panwar VK. Case report of a pituitary macroadenoma treated with artemether. Integr Cancer Ther 2006 Dec;5(4):391-4.
  17. Campos S, de la Cerda P, Rivera A. Fatal artesunate toxicity in a child. Journal of Pediatric Infectious Diseases 2008;3(1):69-75.
  18. Panossian LA, Garga NI, Pelletier D. Toxic brainstem encephalopathy after artemisinin treatment for breast cancer. Ann Neurol 2005 Nov;58(5):812-3.
  19. Gordi T, Lepist EI. Artemisinin derivatives: toxic for laboratory animals, safe for humans? Toxicol Lett 2004 Mar 1;147(2):99-107.
  20. Shen M, Ge HL, He YX, Song QL, Zhang HZ. Immunosuppressive action of Qinghaosu. Sci Sin B 1984 Apr;27(4):398-406.
  21. Brinker F. Herb Contraindictions and Drug Interactions. Ecletic Medical Publications 2001
  22. Skyles AJ, Sweet BV. Alternative therapies. Wormwood. Am J Health Syst Pharm 2004 Feb 1;61(3):239-42.